These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 19632931

  • 1. Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin.
    Sharief U, Perry DJ.
    Clin Colorectal Cancer; 2009 Jul; 8(3):163-5. PubMed ID: 19632931
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A case of reversible posterior leukoencephalopathy syndrome(RPLS)induced by modified FOLFOX6].
    Matsunaga M, Miwa K, Araki K, Sunakawa Y, Yamashita K, Kaneta T, Nakayama H, Noguchi T, Nagashima F, Sasaki Y.
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1283-6. PubMed ID: 22902460
    [Abstract] [Full Text] [Related]

  • 4. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
    Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA.
    Clin Neurol Neurosurg; 2010 Dec; 112(10):886-91. PubMed ID: 20800343
    [Abstract] [Full Text] [Related]

  • 5. Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy.
    Xie L.
    J Oncol Pharm Pract; 2023 Sep; 29(6):1503-1509. PubMed ID: 37218162
    [Abstract] [Full Text] [Related]

  • 6. Reversible posterior leukoencephalopathy syndrome induced by vinorelbine.
    Chen YH, Huang CH.
    Clin Breast Cancer; 2012 Jun; 12(3):222-5. PubMed ID: 22424944
    [Abstract] [Full Text] [Related]

  • 7. [A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)].
    Nagata Y, Omuro Y, Shimoyama T, Sasaki E, Okamoto R, Maeda Y, Kishida S, Sasaki T.
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1163-6. PubMed ID: 19620809
    [Abstract] [Full Text] [Related]

  • 8. Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs.
    Marinella MA, Markert RJ.
    Intern Med J; 2009 Dec; 39(12):826-34. PubMed ID: 19220526
    [Abstract] [Full Text] [Related]

  • 9. Extended use dexamethasone-associated posterior reversible encephalopathy syndrome with cisplatin-based chemotherapy.
    Nguyen MT, Virk IY, Chew L, Villano JL.
    J Clin Neurosci; 2009 Dec; 16(12):1688-90. PubMed ID: 19800799
    [Abstract] [Full Text] [Related]

  • 10. [Reversible posterior encephalopathy syndrome: case report].
    Fernandes FJ, Machado MA, Pedreira AV, Silva CI, Tavares HC, Barbosa VA.
    Arq Neuropsiquiatr; 2002 Sep; 60(3-A):651-55. PubMed ID: 12244391
    [Abstract] [Full Text] [Related]

  • 11. Clinical spectrum of reversible posterior leukoencephalopathy syndrome.
    Lee VH, Wijdicks EF, Manno EM, Rabinstein AA.
    Arch Neurol; 2008 Feb; 65(2):205-10. PubMed ID: 18268188
    [Abstract] [Full Text] [Related]

  • 12. Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.
    Ryan SA, Maceneaney P, O'Reilly SP, Moylan EJ, Power DG.
    Med Oncol; 2012 Jun; 29(2):1287-91. PubMed ID: 21390516
    [Abstract] [Full Text] [Related]

  • 13. [Clinical features of preeclampsia-eclampsia patients with reversible posterior leukoencephalopathy syndrome].
    Lu HY, Xie BD, Cheng Y, Niu XM.
    Zhonghua Yi Xue Za Zhi; 2010 Jan 19; 90(3):178-81. PubMed ID: 20356553
    [Abstract] [Full Text] [Related]

  • 14. Reversible posterior leukoencephalopathy syndrome: a case presentation.
    Bell AJ.
    Neurodiagn J; 2012 Mar 19; 52(1):20-33. PubMed ID: 22558644
    [Abstract] [Full Text] [Related]

  • 15. [Clinical report of posterior leukoencephalopathy syndrome].
    Akhvlediani R, Mogylevsky A, Contant S.
    Georgian Med News; 2008 Jan 19; (154):22-6. PubMed ID: 18323587
    [Abstract] [Full Text] [Related]

  • 16. Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil.
    Truman N, Nethercott D.
    Clin Colorectal Cancer; 2013 Mar 19; 12(1):70-2. PubMed ID: 22917935
    [No Abstract] [Full Text] [Related]

  • 17. Reversible posterior leukoencephalopathy syndrome: a retrospective study in King Chulalongkorn Memorial Hospital.
    Tungkasaereerak C, Phanthumchinda K.
    J Med Assoc Thai; 2008 Mar 19; 91(3):427-32. PubMed ID: 18575300
    [Abstract] [Full Text] [Related]

  • 18. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
    Chang Y, Mbeo G, Littman SJ.
    J Gastrointest Cancer; 2012 Sep 19; 43(3):505-7. PubMed ID: 21556724
    [Abstract] [Full Text] [Related]

  • 19. Posterior reversible encephalopathy syndrome.
    Yasuhara T, Tokunaga K, Hishikawa T, Ono S, Miyoshi Y, Sugiu K, Date I.
    J Clin Neurosci; 2011 Mar 19; 18(3):406-9. PubMed ID: 21236681
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.